NCT04543734View on ClinicalTrials.gov

The Potential of HemoScreen for Monitoring Blood Values in Cancer Patients at Home

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

September 11, 2020

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Cancer
Interventions
DEVICE

HemoScreen hematology analyzer

The use of HemoScreen for self-testing of blood values

Trial Locations (1)

4700

Zealand University Hospital, Oncology, Næstved

All Listed Sponsors
lead

Niels Henrik Holländer

OTHER

NCT04543734 - The Potential of HemoScreen for Monitoring Blood Values in Cancer Patients at Home | Biotech Hunter | Biotech Hunter